Stavros Spiliopoulos, MD, PhD; Stavros Grigoriadis, MD, MSc, PhD; Konstantinos Palialexis, MD, MSc, PhD; Constantine N. Antonopoulos, MD, PhD; George S. Sfyroeras, MD, PhD
A 72-year-old woman with a 10-year history of type 2 DM, arterial hypertension, and hyperlipidemia presented with longstanding lower-extremity IC affecting her left leg.
A 72-year-old woman with a 10-year history of type 2 DM, arterial hypertension, and hyperlipidemia presented with longstanding lower-extremity IC affecting her left leg.
Michael Lichtenberg, MD, FESC; Charles J. Bailey, MD, RPVI, FSVS
Existing evidence on endovascular treatment of BTK arterial disease underscores the persistent challenge of achieving durable luminal patency. Despite technical advances, early mechanical and late biological failure after balloon angioplasty...
Existing evidence on endovascular treatment of BTK arterial disease underscores the persistent challenge of achieving durable luminal patency. Despite technical advances, early mechanical and late biological failure after balloon angioplasty...
This review summarizes results from the RESTORE ATK and RESTORE BTK studies, which looked at the safety and efficacy of the SEISMIQ IVL system (Boston Scientific).
This review summarizes results from the RESTORE ATK and RESTORE BTK studies, which looked at the safety and efficacy of the SEISMIQ IVL system (Boston Scientific).
Dr Sonya Noor explains why TCAR’s flow-reversal neuroprotection, reproducible workflow, and growing evidence base make it an important contemporary option.
Dr Sonya Noor explains why TCAR’s flow-reversal neuroprotection, reproducible workflow, and growing evidence base make it an important contemporary option.
In this video interview, a patient who had been told they were out of options for limb salvage describes traveling from New York City to the Boston area to pursue a new limb-sparing procedure not otherwise available to them.
In this video interview, a patient who had been told they were out of options for limb salvage describes traveling from New York City to the Boston area to pursue a new limb-sparing procedure not otherwise available to them.
Attorney Jason Greis discusses how AI-driven downcoding is affecting physician practices, highlighting repeated audits or downcoding of the same CPT codes as key warning signs.
Attorney Jason Greis discusses how AI-driven downcoding is affecting physician practices, highlighting repeated audits or downcoding of the same CPT codes as key warning signs.
A 2026 retrospective study of patients with solitary unresectable hepatocellular carcinoma found that transarterial radioembolization was associated with longer adjusted overall survival and local progression-free survival than transarterial...
A 2026 retrospective study of patients with solitary unresectable hepatocellular carcinoma found that transarterial radioembolization was associated with longer adjusted overall survival and local progression-free survival than transarterial...
The EU Joint Action Networks of Expertise on Cancer (JANE-2) green paper examines emerging applications and strategies for integrating physical tumor ablation methods into oncology care.
The EU Joint Action Networks of Expertise on Cancer (JANE-2) green paper examines emerging applications and strategies for integrating physical tumor ablation methods into oncology care.
Adding selective radiofrequency ablation after transarterial chemoembolization significantly improved survival outcomes among patients with liver-confined, unresectable hepatocellular carcinoma, according to the phase 3 TORCH randomized...
Adding selective radiofrequency ablation after transarterial chemoembolization significantly improved survival outcomes among patients with liver-confined, unresectable hepatocellular carcinoma, according to the phase 3 TORCH randomized...
Histotripsy demonstrated high technical success and an encouraging safety profile for the treatment of primary and secondary liver tumors in the first systematic review and meta-analysis to report the technology's clinical evidence.
Histotripsy demonstrated high technical success and an encouraging safety profile for the treatment of primary and secondary liver tumors in the first systematic review and meta-analysis to report the technology's clinical evidence.
Salt Lake City (UT) – Fluidx Medical Technology, Inc. announced the positive results from the Investigational Device Exemption (IDE) pivotal clinical trial evaluating the GPX Embolic Device. In the 114 patients that were treated in the trial,...
Salt Lake City (UT) – Fluidx Medical Technology, Inc. announced the positive results from the Investigational Device Exemption (IDE) pivotal clinical trial evaluating the GPX Embolic Device. In the 114 patients that were treated in the trial,...
Michael Pishvaian, MD, PhD, discusses the phase 3 TIGeR-PaC study evaluating intra-arterial gemcitabine among patients with locally advanced pancreatic cancer.
Michael Pishvaian, MD, PhD, discusses the phase 3 TIGeR-PaC study evaluating intra-arterial gemcitabine among patients with locally advanced pancreatic cancer.
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Naina G. Subherwal; Simran P. Subherwal; Sreejit Nair, MD; Ashwani Sastry, MD
This review synthesized 31 studies (99,600 day case procedures; 2000-2024) plus U.S. registries and real-world cohorts evaluating outpatient peripheral endovascular intervention (PVI) for peripheral arterial disease.
This review synthesized 31 studies (99,600 day case procedures; 2000-2024) plus U.S. registries and real-world cohorts evaluating outpatient peripheral endovascular intervention (PVI) for peripheral arterial disease.
Global pioneer of embolotherapy and leading U.S. interventional radiologist join forces with CUC America to build a scalable Office-Based Laboratory (OBL) platform
New Baltimore, MI — April 9, 2026 — CUC America, a leading provider of...
Global pioneer of embolotherapy and leading U.S. interventional radiologist join forces with CUC America to build a scalable Office-Based Laboratory (OBL) platform
New Baltimore, MI — April 9, 2026 — CUC America, a leading provider of...
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Dr Walker comments on the article by Randhawa, Thomas, and Siah entitled “Deep Vein Arterialization for No-Option Chronic Limb-Threatening Ischemia: An Overview of the LimFlow System and CLariTI Study”.
Dr Walker comments on the article by Randhawa, Thomas, and Siah entitled “Deep Vein Arterialization for No-Option Chronic Limb-Threatening Ischemia: An Overview of the LimFlow System and CLariTI Study”.
McCall Walker, MD; Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP; Sahil A. Parikh, MD, FACC, FSCAI; Matthew T. Finn, MD, MS
In light of recent reports alleging overuse of atherectomy devices, the authors revisit the guidelines and clinical data as to inform the overall discourse surrounding the appropriate use of these devices.
In light of recent reports alleging overuse of atherectomy devices, the authors revisit the guidelines and clinical data as to inform the overall discourse surrounding the appropriate use of these devices.
Stavros Spiliopoulos, MD, PhD; Stavros Grigoriadis, MD, MSc, PhD; Konstantinos Palialexis, MD, MSc, PhD; Constantine N. Antonopoulos, MD, PhD; George S. Sfyroeras, MD, PhD
A 72-year-old woman with a 10-year history of type 2 DM, arterial hypertension, and hyperlipidemia presented with longstanding lower-extremity IC affecting her left leg.
A 72-year-old woman with a 10-year history of type 2 DM, arterial hypertension, and hyperlipidemia presented with longstanding lower-extremity IC affecting her left leg.
Tom Davis, MD; Peter Dovgan, MD; Eric J. Dippel, MD
This retrospective observational case series evaluated embolic debris retrieval and procedural feasibility of temporary occlusion embolectomy during complex peripheral vascular interventions.
This retrospective observational case series evaluated embolic debris retrieval and procedural feasibility of temporary occlusion embolectomy during complex peripheral vascular interventions.
Alberto Francesco Cereda, MD; Marco Biolcati, MD; Federico Biondi, MD; Marco Stracqualursi, MD; Antonio Gabriele Franchina, MD; Lorenzo Tua, MD; Stefano Lucreziotti, MD
This meta-analysis assesses the association between peak anti-Xa levels and bleeding events in patients treated with apixaban or rivaroxaban.
This meta-analysis assesses the association between peak anti-Xa levels and bleeding events in patients treated with apixaban or rivaroxaban.
John H. Shao, MD; John Lee, MD; Haris Umer Usman, MD, MS
The authors describe the successful application of PTAB utilizing the Detour system (Endologix) as a limb salvage strategy for a patient with previously failed femoropopliteal bypass.
The authors describe the successful application of PTAB utilizing the Detour system (Endologix) as a limb salvage strategy for a patient with previously failed femoropopliteal bypass.
Stavros Spiliopoulos, MD, PhD; Stavros Grigoriadis, MD, MSc, PhD; Konstantinos Palialexis, MD, MSc, PhD; Constantine N. Antonopoulos, MD, PhD; George S. Sfyroeras, MD, PhD
A 72-year-old woman with a 10-year history of type 2 DM, arterial hypertension, and hyperlipidemia presented with longstanding lower-extremity IC affecting her left leg.
A 72-year-old woman with a 10-year history of type 2 DM, arterial hypertension, and hyperlipidemia presented with longstanding lower-extremity IC affecting her left leg.
Attorney Jason Greis discusses how AI-driven downcoding is affecting physician practices, highlighting repeated audits or downcoding of the same CPT codes as key warning signs.
Attorney Jason Greis discusses how AI-driven downcoding is affecting physician practices, highlighting repeated audits or downcoding of the same CPT codes as key warning signs.
Drawing on current data and clinical experience, Dr Wilkins highlights the importance of thoughtful patient selection and lesion-specific decision-making to maximize outcomes.
Drawing on current data and clinical experience, Dr Wilkins highlights the importance of thoughtful patient selection and lesion-specific decision-making to maximize outcomes.
A 2026 retrospective study of patients with solitary unresectable hepatocellular carcinoma found that transarterial radioembolization was associated with longer adjusted overall survival and local progression-free survival than transarterial...
A 2026 retrospective study of patients with solitary unresectable hepatocellular carcinoma found that transarterial radioembolization was associated with longer adjusted overall survival and local progression-free survival than transarterial...
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
“The academic PRAGUE-26 trial aimed to challenge the current standard of care in intermediate–high risk acute pulmonary embolism by determining whether conventional CDT (without ultrasound facilitation) can improve on anticoagulation...
“The academic PRAGUE-26 trial aimed to challenge the current standard of care in intermediate–high risk acute pulmonary embolism by determining whether conventional CDT (without ultrasound facilitation) can improve on anticoagulation...
NYU Langone Health has appointed Sunil Rao, MD, an internationally recognized clinician-investigator whose work has introduced new approaches to treating patients with complex cardiovascular conditions, as director of the Leon H. Charney...
NYU Langone Health has appointed Sunil Rao, MD, an internationally recognized clinician-investigator whose work has introduced new approaches to treating patients with complex cardiovascular conditions, as director of the Leon H. Charney...
The longer-length Esprit addresses a real-world clinical need: most below-the-knee lesions in CLTI patients exceed 100 mm, while existing lengths can require multiple scaffolds, increasing procedural time and complexity.
The longer-length Esprit addresses a real-world clinical need: most below-the-knee lesions in CLTI patients exceed 100 mm, while existing lengths can require multiple scaffolds, increasing procedural time and complexity.
Radiation Detection Company (RDC) launched Radiant real-time dosimetry, a connected electronic dosimetry solution designed to provide clinicians with immediate visibility into radiation levels during high-exposure medical procedures.
Radiation Detection Company (RDC) launched Radiant real-time dosimetry, a connected electronic dosimetry solution designed to provide clinicians with immediate visibility into radiation levels during high-exposure medical procedures.
The technology has the potential to enable autonomous remote treatment of acute ischemic stroke through mechanical thrombectomy without direct human input. Autonomous remote endovascular robotics(1) can help to get the right treatment faster...
The technology has the potential to enable autonomous remote treatment of acute ischemic stroke through mechanical thrombectomy without direct human input. Autonomous remote endovascular robotics(1) can help to get the right treatment faster...
The EU Joint Action Networks of Expertise on Cancer (JANE-2) green paper examines emerging applications and strategies for integrating physical tumor ablation methods into oncology care.
The EU Joint Action Networks of Expertise on Cancer (JANE-2) green paper examines emerging applications and strategies for integrating physical tumor ablation methods into oncology care.
